30
Participants
Start Date
February 5, 2024
Primary Completion Date
April 25, 2024
Study Completion Date
April 26, 2024
Obicetrapib
oral administration
Obicetrapib + Drospirenone / Ethinyl Estradiol (COC)
oral administration
Drospirenone / Ethinyl Estradiol (COC)
oral administration
NOVUM, Las Vegas
Lead Sponsor
Novum
INDUSTRY
NewAmsterdam Pharma
INDUSTRY